• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS T4; TOTAL THYROXINE ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS T4; TOTAL THYROXINE ASSAY Back to Search Results
Catalog Number ASKU
Device Problems Incorrect Measurement (1383); High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/06/2023
Event Type  malfunction  
Manufacturer Narrative
The serial number of the e 801 analyzer is (b)(6).The full e1 facility name was provided as "sichuan provincial people's hospital sichuan provincial people's hospital".The patient sample was provided for investigation.The investigation is ongoing.
 
Event Description
The initial reporter stated they received questionable results for one patient sample tested with elecsys t3 and elecsys t4 on a cobas e 801 analytical unit.The customer states that the t3 and t4 values were abnormally elevated, but tsh was normal.The results were not in line with the patient's clinical manifestations.No questionable results were reported outside of the laboratory.This medwatch will apply to the t4 assay.Please refer to the medwatch with a1.Patient identifier (b)(6) for information related to the t3 assay.Refer to the attachment for the patient's results.The t3 and t4 values from the 06-nov-2023 sample are questioned.The sample was repeated after the patient sample was treated with the streptavidin-coated microparticle portion of the t3 and t4 reagents.For this treatment, the sample and microparticle portion of the reagents were incubated at 37 degrees celcius for 30 minutes, the supernatant was then centrifuged and tested.
 
Manufacturer Narrative
Investigations of the sample were able to reproduce the results obtained by the customer.Further investigations of the sample determined that it contains an interfering factor against the streptavidin component of the t3 and t4 assays.Per product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin, or ruthenium can occur.These effects are minimized by suitable test design." the investigation did not identify a product issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS T4
Type of Device
TOTAL THYROXINE ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250-0457
MDR Report Key18232768
MDR Text Key329700126
Report Number1823260-2023-03794
Device Sequence Number1
Product Code CDX
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K962508
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/06/2023
Initial Date FDA Received11/29/2023
Supplement Dates Manufacturer Received12/11/2023
Supplement Dates FDA Received12/13/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age53 YR
Patient SexFemale
Patient RaceAsian
-
-